According to Ramsay Générale de Santé's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 9.29223. At the end of 2023 the company had a P/E ratio of 44.9.
Year | P/E ratio | Change |
---|---|---|
2023 | 44.9 | 113.47% |
2022 | 21.0 | -34.7% |
2021 | 32.2 | -77.53% |
2020 | 143 | -21.68% |
2019 | 183 | -0.9% |
2018 | 185 | 790.64% |
2017 | 20.7 | -23.33% |
2016 | 27.0 | |
2014 | 44.0 | 566.34% |
2013 | 6.60 | -32.86% |
2012 | 9.83 | -154.6% |
2011 | -18.0 | -206.68% |
2010 | 16.9 | -3.91% |
2009 | 17.6 | 125.34% |
2008 | 7.79 | -71.64% |
2007 | 27.5 | 301.51% |
2006 | 6.84 | -75.31% |
2005 | 27.7 | 25.97% |
2004 | 22.0 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.